Brazil’s Pharmacovigilance: The Program of Risk Management and Pharmaceutical Technology of Vaccines

A guide prepared by Anvisa provides guidance to development companies on procedures for emergency use authorization of Covid-19 vaccines.
A guide prepared by Anvisa provides guidance to development companies on procedures for emergency use authorization of Covid-19 vaccines.
Copyright ©2023 Global Regulatory Partners